Table 4.
Comparison between corticosteroid with or without additional etanercept treatment on Sotozono's acute and chronic stage grading score.
| Corticosteroid + | Corticosteroid | p-value | |
|---|---|---|---|
| etanercept | only | ||
| Number (patient/eye) | 31/62 | 82/164 | |
| Gender (M/F) | 15/16 | 32/50 | 0.126 |
| Age (years old) | 48.00 ± 18.72 | 45.79 ± 24.06 | 0.601 |
| Mean follow up time (days) | 485.00 ± 502.42 | 360.82 ± 319.64 | 0.319 |
| Time to intervention (days) | 1.96 ± 1.49 | 0.78 ± 0.64 | 0.003 |
| Major causative drugs | |||
| Anti-epileptics | 24 (38.71%) | 48 (29.27%) | 0.264 |
| Antibiotics | 11 (17.74%) | 26 (15.58%) | |
| Allopurinol | 6 (9.68%) | 10 (6.10%) | |
| NSAID | 6 (9.68%) | 26 (15.58%) | |
| Sulfa drugs | 2 (3.23%) | 18 (10.98%) | |
| Others | 13 (20.97%) | 36 (21.95%) | |
| Sotozono's grading score | |||
| Acute stage | |||
| Mean | 1.323 | 1.488 | 0.171 |
| Std. deviation | 0.763 | 0.903 | |
| Std. Error Mean | 0.097 | 0.071 | |
| Chronic stage | |||
| Mean | 1.645 | 3.951 | <0.001 |
| Std. deviation | 2.470 | 5.765 | |
| Std. error mean | 0.314 | 0.450 | |